ÌìÃÀÓ°Ôº

Summary: In this interview with Pharmtech, Karunakar Sukuru, Global Vice President, Rx Product Development, Pharma and Consumer Health, ÌìÃÀÓ°Ôº shares his thoughts on the key benefits of Lipid based formulations (LBF.)

Summary: This executive summary showcases examples of real-life tactical and operational decisions involved in the integrated approach to drug development.

Summary: In this webinar, industry experts will discuss how a manufacturing on-demand strategy can enhance your clinical development and improve drug supply utilization.

Summary: In this article, Dr. Alan Watts, Director of Innovation & Partnerships for Orally Inhaled Products at ÌìÃÀÓ°Ôº, and Michael Tauber, Senior Director of Pharmaceutical Development at Acorda Therapeutics discuss the requirements and benefits of using spray-dried powders for inhalation, and how ARCUS can be used to successfully bring new inhaled therapies to market.

Summary: This article discusses how to successfully develop and manufacture spray-dried pulmonary and nasal powders and how a CDMO partner plays an integral role in the successful development and commercialization of inhalation products.

Summary: Download this fact sheet to learn more about our experience and expertise with nitrosamines testing.

Summary: ÌìÃÀӰԺ’s Nottingham facility specializes in early phase development of small molecule drug candidates and complex molecules from bench to clinic through integrated offerings such as...

Summary: In this webinar, experts will discuss the advantages of LBFs and softgels while addressing the ongoing challenges in realizing their full clinical and commercial potential.

Industry experts discuss how QbD strategies can be applied in the systematic evaluation of small batches of spray-dried solid dispersions for oral delivery.

Summary: Download this article to gain insights into the perceived barriers to developing LBFs and recent advances in translating them into useful clinical and commercial products of lipophilic drugs.